![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 38/00 | (2006.01) |
A61K 38/10 | (2013.01) | ||
A61K 38/10 | (2006.01) | ||
A61K 38/39 | (2013.01) | ||
A61K 38/39 | (2006.01) | ||
A61P 7/10 | (2018.01) | ||
A61P 9/10 | (2006.01) | ||
A61P 9/10 | (2018.01) | ||
A61K 38/00 | (2013.01) | ||
Y02A 50/30 | (2018.01) |
(11) | Patento numeris | 3522906 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17859077.4 |
Europos patento paraiškos padavimo data | 2017-10-04 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-08-14 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2022-03-23 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2017/055055 |
Data | 2017-10-04 |
(87) | Numeris | WO 2018/067646 |
Data | 2018-04-12 |
(30) | Numeris | Data | Šalis |
201662403786 P | 2016-10-04 | US |
(72) |
PANDEY, Niranjan, B. , US
MIRANDO, Adam , US
POPEL, Aleksander, S. , US
GREEN, Jordan, J. , US
|
(73) |
Asclepix Therapeutics, Inc. ,
301 West 29th Street, Suite 2004, Baltimore, MD 21211,
US
The Johns Hopkins University , 3400 North Charles Street, Baltimore, MD 21218, US |
(54) | COMPOUNDS AND METHODS FOR ACTIVATING TIE2 SIGNALING |
COMPOUNDS AND METHODS FOR ACTIVATING TIE2 SIGNALING |